M4MM
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
Earnings Season: Cannabis Operators Deliver a Different Kind of Q2 2026
LOS ANGELES – The Cannabis industry wraps up its second-quarter earnings, and the aggregate picture carries a theme that would have been harder to locate a few years ago. Operators are making money. Profitability, not ...
Yale Budget Lab Outlines Multibillion Dollar Future for Federal Cannabis
NEW HAVEN – The fiscal argument for federal Cannabis legalization now has an academic backbone. Yale University's Budget Lab released a comprehensive revenue analysis mapping out what a federal excise tax on Cannabis could realistically ...
Definium Delivers Positive Phase 3 Data for LSD Candidate in GAD
NEW YORK – Definium Therapeutics Inc. has released topline results from the first of two Phase 3 studies testing its LSD-based candidate DT120 in adults with generalized anxiety disorder (GAD). The findings add to earlier ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – A hostile takeover bid, a Senate hemp vote that reset the enforcement calendar without solving anything, a state tax repeal with constitutional teeth, a dense Q2 earnings wave, and two landmark banking ...
Michigan Lawmakers Push to Repeal 24% Cannabis Tax
LANSING – Less than eight months after Michigan imposed a new wholesale Cannabis tax to shore up its road repair budget, a Republican state lawmaker has introduced legislation to eliminate it entirely. House Bill 6224, ...
Glass House Brands Reports Q2 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its Q2 2026 financial results, reporting revenue of $47 million, nearly flat year-over-year but a 64% sequential improvement from Q1 2026. Biomass production reached a company record ...
Curaleaf Launches $272 Million Hostile Takeover Battle for Aurora Cannabis
NEW YORK - Curaleaf Holdings has launched a hostile takeover battle for Aurora Cannabis, publicly announcing plans to take a US$272 million offer directly to Aurora’s shareholders after failing to secure the support of Aurora’s ...
Ohio Cannabis Health & Business Summit Announces 2026 Event in Columbus
The sixth annual OCHBS will take place September 23–24 at the Greater Columbus Convention Center, with expanded programming and expo booths, a medical patient access program, and signature networking events at Stories on High and ...
Vireo Growth Authorizes Share Buyback Program
MINNEAPOLIS – Vireo Growth Inc. has received board approval to begin a share repurchase plan under a normal course issuer bid. Following a series of strategic moves, including an expansion into Ohio and an earlier ...
Tyson 2.0 Teams Up with Reborn Roots for a Heavyweight Touchdown in Rhode Island
LOS ANGELES – Celebrity Cannabis brands have tested markets from the Pacific Northwest to the Caribbean and one of the sector's most recognized names is now pushing into New England. Tyson 2.0 Inc. announced an ...
Ascend Wellness Reports Q2 2026 Financial Results
NEW YORK – Ascend Wellness Holdings Inc. reported its Q2 2026 financial results posting net revenue of $126.1 million, a 7.9% sequential increase from $116.9 million in Q1 2026. Retail revenue climbed 11.5% quarter-over-quarter to ...
